Phyllis Harris' three-decade career as an attorney has taken her to the heights of the for-profit and nonprofit worlds.

Thioglycosides are prominent glycosides in biology and drug discovery because of their unique physicochemical and biological properties. The stereoselective construction of thioglycosides from ...

Covalent organic framework (COF)-based electrocatalysts for water oxidation are usually designed by inducing polarization into an organic framework. The most common methodology “heteroatom insertion” ...

Though the attack on the Federalist Society came as a shock to critics and supporters of Trump, giving the ABA the cold shoulder was not a surprise. Utah Sen. Mike Lee has been very outspoken against ...

The first cohort of students to take advantage of a new tuition-free welding training opportunity offered through Delaware County Community College and Philadelphia Works’ Good Jobs Challenge has ...

CHICAGO — New study results show that a structured exercise program following surgery and adjuvant chemotherapy reduced the risk of recurrent or new cancer and increased survival for patients with ...

“American Ninja Warrior” hosts Matt Iseman and Akbar Gbajabiamila join Saturday TODAY to talk about Season 17 of the competition show. They open up about what surprises people can expect, and ...

Education Department says ban on Native American logos, mascots violated federal civil rights law The U.S. Department of Education’s Office for Civil Rights said an investigation revealed that two New ...

The U.S. is experiencing a shortage of welders, and over 320,500 new welding professionals will be needed by 2029, according to American Welding Society projections.

Hundreds of cyclists are getting ready for the American Cancer Society's 53rd annual Bridge to the Beach Bike-A-Thon on Sunday. A first-time rider and a veteran share the personal experiences ...

The president called the prominent judicial activist Leonard Leo a “real ‘sleazebag’” and said the Federalist Society had led him astray in his first term.

Blinatumomab has rapidly emerged as a cornerstone in the treatment of B-cell ALL (B-ALL) across age and risk groups. Initially approved for minimal residual disease (MRD)–positive adult B-ALL in 2018, ...